1. A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia. Issue 16 (2nd May 2021) Authors: Borthakur, Gautam; Odenike, Olatoyosi; Aldoss, Ibrahim; Rizzieri, David A.; Prebet, Thomas; Chen, Chris; Popovic, Relja; Modi, Dimple A.; Joshi, Rujuta H.; Wolff, Johannes E.; Jonas, Brian A. Journal: Cancer Issue: Volume 127:Issue 16(2021) Page Start: 2943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mutant p53 expression in fallopian tube epithelium drives cell migration. Issue 7 (11th April 2015) Authors: Quartuccio, Suzanne M.; Karthikeyan, Subbulakshmi; Eddie, Sharon L.; Lantvit, Daniel D.; Ó hAinmhire, Eoghainín; Modi, Dimple A.; Wei, Jian‐Jun; Burdette, Joanna E. Journal: International journal of cancer Issue: Volume 137:Issue 7(2015:Oct. 01) Page Start: 1528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗